Jim Cramer’s Big Prediction About CVS Health (CVS) Turned Out To Be Right

We recently published Jim Cramer Said Sandisk Stock Performance is Befuddling & Discussed These 17 Stocks. CVS Health Corporation (NYSE:CVS) is one of the stocks discussed by Jim Cramer.

CVS Health Corporation (NYSE:CVS) continues to be favored by Jim Cramer in the pharmaceutical retailer space. Its shares are up by 30% over the past year and by 8.4% year-to-date. Cramer has discussed CVS Health Corporation (NYSE:CVS) several times over the past couple of months and praised the firm’s management at being able to operate well in an otherwise tumultuous industry. Baird raised the share price target to $94 from $92 and kept an Outperform rating on the stock on April 15th. Other analysts had discussed CVS Health Corporation (NYSE:CVS)’s settlement with the FTC as part of their earlier coverage. In this appearance, Cramer predicted that the firm’s upcoming quarter results would be good. He was proven right as CVS Health Corporation (NYSE:CVS) posted $100.43 billion in revenue and $2.57 in earnings per share to beat analyst estimates of $95.09 billion and $2.20.

“Rite Aid disappeared, Walgreens seems to be going away. CVS has a good quarter coming up, I think, but that’s because of Aetna.”

Jim Cramer's Big Prediction About CVS Health (CVS) Turned Out To Be Right

Pixabay/Public Domain

While we acknowledge the risk and potential of CVS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CVS and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.